Eulerpool Terminal
The edge that pays for itself.
Current Mankind Pharma forecasts and price targets in August 2026
Ø Analyst Price Targets
2,686.27 INR
+12.03 %
Median
2,606.10 INR
+8.68 %
Max
3,423.00 INR
Min
2,009.90 INR
Last Price
2,397.90 INR
Buy
16
Hold
4
Sell
2
The average target price for Mankind Pharma is 2,686.27 INR. (+12.03 % above the current price)
The median price target of Mankind Pharma is 2,606.10 INR.
Stock analysts from many renowned investment banks are closely examining the Mankind Pharma stock. They conclude their professional Mankind Pharma stock analyses with a clear recommendation for the Mankind Pharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 16 | 4 | 2 | 2,686.27 INR |
| 2026-01-01 | 15 | 5 | 2 | 2,702.46 INR |
| 2025-12-01 | 15 | 5 | 2 | 2,694.98 INR |
| 2025-12-01 | 15 | 5 | 2 | 2,694.98 INR |
| 2025-11-01 | 15 | 5 | 2 | 2,724.22 INR |
| 2025-11-01 | 15 | 5 | 2 | 2,865.95 INR |
Mankind Pharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Mankind Pharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 142.69 B INR | 18.82 B INR | 46.49 INR |
| 2027e | 159.59 B INR | 23.67 B INR | 58.48 INR |
| 2028e | 177.81 B INR | 28.82 B INR | 71.21 INR |